Despite being a top cannabis market in the United States, Michigan largely has been ignored by multistate operators because of the low barriers to entry for new licensees.
Read More
EMAIL: kevinh@MJBizDaily.com
PHONE: 720.575.5528
PHONE: 720.575.5528
Pennsylvania is a hotbed for cannabis M&A
On July 12, Verano Holdings Corp. (CSE: VRNO; OTCQX: VRNOF) closed its acquisition of all outstanding and issued equity interests in Agri-Kind, Pennsylvania cultivator and processor, and Agronomed Holdings.
Read More
MJBizDaily honored for coverage of 2020 election, COVID-19 pandemic
MJBizDaily and MJBizMagazine won two Tabbie awards for excellence in trade journalism, the Trade Association Business Publications International (TABPI) announced. The organization awarded a silver medal in the Special Section category to “Marijuana on the Ballot,” MJBizMagazine’s October cover story about the 2020 U.S. general election. Describing the winning entry, TABPI said the package represented […]
Read More
Harborside expands California cannabis presence + debt options remain limited
On July 5, Harborside (CSE: HBOR; OTCQX: HBORF), a California-based vertically integrated operator, closed its acquisition of Sublimation (“Sublime”).
Read More
More multistate operators target Florida cannabis market
Discounts lead to market-share shift in Florida Florida, one of the most valuable cannabis markets in the world, is beginning to see competition among the top players – and the state’s patients are reaping the benefits of the undercutting. Despite the attractive structure of Florida’s limited licensed medical program, described recently in MJBizFinance, few operators […]
Read More
Push to legalize medical cannabis in North Carolina makes progress
The North Carolina Senate Judiciary Committee voted in favor of a plan to legalize medical cannabis use for certain conditions. The Wednesday action, though an extremely preliminary step in the process, signified the first time a North Carolina Senate committee took a vote involving a marijuana measure, according to Raleigh-based TV station WRAL. Senate Bill […]
Read More
Where a cannabis company trades can have a big impact on liquidity, valuation
Though access to capital for public cannabis companies improved in early 2021, liquidity remains low for the U.S. plant-touching operators in comparison to the Canadian licensed producers. U.S. operators have access only to lower-volume exchanges, such as the Canadian Securities Exchange (CSE) and the over-the-counter-market, which allow “touching the plant” in the U.S., because the […]
Read More
Investors key in on social equity, sustainability – even in cannabis
While business fundamentals will – and absolutely should – continue to be critical factors in investments, more funds are adapting their models to include activities viewed as beneficial to the broader world, including: Sustainability Social equity The shift isn’t just in cannabis. More individual investors want to ensure their dollars are going to firms that […]
Read More
US cannabis sales off to strong start in 2021
Cannabis sales in 2021 were expected to be muted, relative to sales in 2020, but instead, transaction volume from new consumers supported unexpectedly high growth rates early this year. Last year, the cannabis industry experienced multiple unique sales accelerators, and those catalysts have carried into 2021. 2020 started with Illinois and Massachusetts, ranked Nos. 5 […]
Read More
NFL to spend $1 million researching medical cannabis pain management
The National Football League’s pain management committee and the NFL Players Association said they will provide $1 million to fund up to five research grants on the impact of medical cannabis and other cannabinoids on pain.
Read More
Debt market cautious about Hexo’s ability to integrate cannabis acquisitions
Last week, Hexo Corp. (TSX: HEXO; NYSE: HEXO) closed a public offering of $360 million principal amount of senior secured convertible notes maturing May 1, 2023.
Read More
Bad actors to blame for inaccurate cannabis labels? Not so fast
All cannabis consumers have a right to confidently know the contents of the products they purchase. But ongoing random, observational and longitudinal studies have demonstrated that many product labels in the cannabis sector don’t concur with independent analytical test results. Many in the cannabis industry have come to regard some as “bad players” when labels […]
Read MoreAugust Issue
